Overview
Feiran Lou is a Thoracic Surgeon in Worcester, Massachusetts. Dr. Lou has been practicing medicine for over 18 years and is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Endoscopy. Dr. Lou is currently accepting new patients.
Her clinical research consists of co-authoring 34 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
67 Belmont St, Worcester, MA 01605
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Brigham And Women's Hospital, Lung Center
Dr. Steven J. Mentzer is a thoracic surgeon at Brigham and Women’s Hospital and Dana-Farber Brigham Cancer Center. He is a professor of surgery at Harvard Medical School.Dr. Mentzer received his medical degree from the University of Minnesota and received his general surgical residency training at the Brigham. He completed a cardiothoracic surgery fellowship at the University of Toronto. Dr. Mentzer also completed a research fellowship at Dana-Farber Cancer Institute where he investigated the molecular mechanisms involved in the regulation of T lymphocyte function. He is board certified in surgery, cardiothoracic surgery, and surgical critical care.Dr. Mentzer’s clinical interests include diseases of the lungs and thoracic cancers, minimally invasive surgery of the lungs and esophagus, and minimally invasive surgery for esophageal cancer. Principal investigator for The Mentzer Lab, Dr. Mentzer is currently studying the adaptive processes involved in blood vessel growth (angiogenesis) and lung regeneration. Dr. Mentzer is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), ALK-Positive Non-Small Cell Lung Cancer, Gastrostomy, and Endoscopy.
Brigham And Women's Hospital, Lung Center
Dr. Jon Wee is the Esophageal Surgery Section Chief, Director of Robotics in Thoracic Surgery, and co-Director of Minimally Invasive Thoracic Surgery at Brigham and Women’s Hospital. He is also an Associate Program Director for Thoracic Surgery and is an Assistant Professor of Surgery at Harvard Medical School.Dr. Wee received his medical degree from the Duke University School of Medicine and completed his surgical training at Brigham and Women’s Hospital. He then went on to complete his cardiothoracic surgery training at the University of Pittsburgh Medical Center. He is board certified in surgery and thoracic surgery.Dr. Wee’s clinical interest is in minimally invasive approaches to thoracic diseases. These include minimally invasive and robotic esophagectomy, lobectomy, thymectomy and mediastinal resection for thoracic malignancies. In addition, he treats benign esophageal disease such as gastro-esophageal reflux disease, giant paraesophageal hernias, diverticulum, etc. He performs POEM procedures for achalasia as well as sympathectomy for hyperhidrosis and endoluminal therapies such as PDT, laser, and stents for palliation. His research interest is in the use of minimally invasive techniques to decrease pain, improve recovery, and improve ultimate outcomes. Dr. Wee is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Nodules, Endoscopy, and Thymectomy.
Scott Swanson is a Thoracic Surgeon and a General Surgeon in Boston, Massachusetts. Dr. Swanson is rated as an Elite provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, Endoscopy, and Mastectomy. Dr. Swanson is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerDr. Lou isDistinguished. Learn about Lung Cancer.
- Pleuropulmonary BlastomaDr. Lou isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- EGFR Positive Lung CancerDr. Lou isAdvanced. Learn about EGFR Positive Lung Cancer.
- Lung AdenocarcinomaDr. Lou isAdvanced. Learn about Lung Adenocarcinoma.
- Lung NodulesDr. Lou isAdvanced. Learn about Lung Nodules.
- Non-Small Cell Lung Cancer (NSCLC)
- Squamous Cell Lung Carcinoma
- Experienced
- Collapsed LungDr. Lou isExperienced. Learn about Collapsed Lung.
- EmphysemaDr. Lou isExperienced. Learn about Emphysema.
- EndoscopyDr. Lou isExperienced. Learn about Endoscopy.
- Esophageal PerforationDr. Lou isExperienced. Learn about Esophageal Perforation.
- Fibrosing MediastinitisDr. Lou isExperienced. Learn about Fibrosing Mediastinitis.
- Lymphofollicular HyperplasiaDr. Lou isExperienced. Learn about Lymphofollicular Hyperplasia.


